Sabin Vaccine Institute to Team with Brazilians on Human Hookworm Vaccine Trials

NEW CANAAN, CT, September 15, 2004—The Sabin Vaccine Institute, sponsor of research funded by the Bill & Melinda Gates Foundation on a newly developed vaccine to prevent human hookworm disease, has signed a memorandum of understanding with federal and state vaccine production facilities in Brazil for clinical development of the vaccine, including clinical trials and vaccine manufacture.

Hookworm Disease Weighs Heavily on the Developing World Poor

NEW CANAAN, CT, August 19, 2004—An article published today in The New England Journal of Medicine calls attention to the enormous impact of parasitic hookworm infection on the developing world poor. The authors of “Current Concepts: Hookworm Infection” have studied the parasite over many years and describe the disturbing effects of mild infection as well as the disease state that results from heavy hookworm infection.

Prestigious Sabin Gold Medal Awarded to Physician William S. Jordan, MD

NEW CANAAN, CT—William S. Jordan, Jr., MD, physician, teacher, and noted vaccine researcher will receive the prestigious 2004 Albert B. Sabin Gold Medal at a ceremony on May 25, 2004. Dr. Jordan is the twelfth recipient of this recognition by the scientific community, awarded annually by the Sabin Vaccine Institute to honor achievements by vaccinologists and infectious disease experts.

Sabin Vaccine Institute Honors DNA Scientist James Watson and Biotechnology Pioneer Chiron at Annual Benefit Event

NEW CANAAN, CT—The Sabin Vaccine Institute will celebrate a Salute to Life-Saving Discoveries during its benefit dinner at The Pierre Hotel in New York City May 12. The evening will feature the presentation of awards to Nobel laureate James D. Watson, PhD, and to Howard Pien, president and CEO of Chiron Corporation.

Fifty Years of Miracles: H.R. Shepherd and Peter J. Hotez Recall the Legacy of Vaccine Advances

NEW CANAAN, Conn., April 27 — Fifty years ago, six-year-old Randy Kerr from McLean, Virginia, was officially designated the nation's first child to be vaccinated with an experimental polio vaccine developed by Jonas Salk in his University of Pittsburgh laboratory. Over the next several months thousands of children who became known as "Polio Pioneers" stepped up to receive their polio injections as part of an enormous vaccine field trial.

Pages